Current research predominantly spike protein.
Would you like to contact us today?
Meet Our Team

Christopher Paule
Co-Founder
Dr. Benjamin Larimer
Co-Founder
F.H. "Joe" Gay
Co-FounderMeet Our Advisors
Eric Lee
Board of ManagersEric has been involved in P3 Diagnostics since its pre-formation discussions, and he currently serves on the Board of Managers in a director and non-attorney advisory role. Eric is an experienced attorney, advisor, and director with a diverse background ranging from military service to Chief Legal Officer. His current roles outside of P3 include Chief Legal Officer, Chief Compliance Officer, Data Privacy Officer, Corporate Secretary, and board roles for a multinational company, as well as board roles for other for-profit and not-for-profit companies. Throughout his career, he has served as a lead advisor for founders, family offices, public and private boards, CEOs, CLOs, management teams, operating partners, and others throughout the corporate lifecycle. He brings a practical approach to growth and development and overall management based on a solid understanding of operational and commercial requirements.
You can learn more about Eric here: https://www.linkedin.com/in/sericlee/
Dr. Garima Arvikar
AdvisorDr. Garima Arvikar is a protein engineer currently working as a Postdoctoral Fellow at the University of Alabama at Birmingham in the laboratory of Dr. Benjamin Larimer. Garima received her PhD in biochemistry from The University of Alabama in Dec 2015. Following completion of her degree, she held a postdoctoral fellowship at McMaster University in the laboratory of Dr. Eric Brown where she worked antimicrobial drug discovery. Her current research focuses on the discovery and engineering of novel single domain antibodies for targeted cancer therapy using phage display technology.
Mike Larimer
AdvisorMike is an advisor and key contributor to the phage analysis. He is a multidimensional database expert with over 25 years of experience in the software industry. He holds an MBA from Illinois State University.
News
Dr. Larimer has been given the Innovator Award from NIH
Project Title: Site-Specific Immune Cell Activation Detection for Improving Individualized Cancer Immunotherapy
Grant ID: DP2-CA261453
Funded by the National Cancer Institute
NIH to support 85 new grants featuring high-risk, high-reward research
- National Institutes of Health (NIH)
The 2020 Director’s Awards will feature highly innovative biomedical research by investigators at all career stages.
Key Terms

Structure of 2019-nVCoV

Structural Protein
It has been noted that some CoVs do not need to have the full ensemble of structural proteins to make virions.

Serological Assays
Limitations of sequencing based diagnostic tests
● Do not detect immune response
● Can't monitor duration of response
Serological assays (Our Technology)
● Detect past infection
● Antibody based long-term immunity
● Possibility of transfusions as treatment
● Vaccine development

Serological Testing
● Interactions of host antibody with pathogen / antigen / epitope
● 2019-nCoV-highly infectious
● Recombinant spike protein, specific and labor intensive
● Epitope, non-infectious and small sequences capable of detecting immune response
Contact Us
Don't hesitate to get touch please fill out this form
and we'll get back to you as soon as possible.